|
Sep 16
|
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
|
|
Aug 26
|
DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
|
|
Jan 30
|
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
|
|
Dec 22
|
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
|
|
Nov 28
|
DSS: Q3 2023 Results Show Hesitation from DSS Customers Due to A Worsening Economy and Government Inaction
|
|
Nov 28
|
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
|
|
Nov 15
|
Impact Biomedical Inc. Files Current Report on Form 8-K
|
|
Nov 14
|
DSS Inc. Wins Patent Dispute with Nichia Corporation
|
|
Oct 26
|
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
|
|
Oct 23
|
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
|
|
May 1
|
DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders
|
|
Apr 19
|
DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders
|
|
Apr 18
|
Presenting on the Emerging Growth Conference on April 19 Register Now
|
|
Apr 17
|
DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM
|